BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Santos S, Malheiro J, Tafulo S, Dias L, Carmo R, Sampaio S, Costa M, Campos A, Pedroso S, Almeida M, Martins LS, Henriques C, Cabrita A. Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies. World J Transplant 2016; 6(4): 689-696 [PMID: 28058219 DOI: 10.5500/wjt.v6.i4.689]
URL: https://www.wjgnet.com/2220-3230/full/v6/i4/689.htm
Number Citing Articles
1
Olga A. Timofeeva. Donor-Specific HLA Antibodies as Biomarkers of Transplant RejectionClinics in Laboratory Medicine 2019; 39(1): 45 doi: 10.1016/j.cll.2018.10.007
2
Lovy Gaur, Ajay Kher, Manoj Kumar Singhal. Immunological Complexity of Anti-human Leukocyte Antigen-C Donor-specific Antibodies: Therapeutic Insights from Two CasesIndian Journal of Transplantation 2024; 18(1): 87 doi: 10.4103/ijot.ijot_91_23
3
Jonathan Visentin, Lionel Couzi, Jean‐Luc Taupin. Clinical relevance of donor‐specific antibodies directed at HLA‐C: A long road to acceptanceHLA 2021; 97(1): 3 doi: 10.1111/tan.14106
4
Ajay Kumar Baranwal, Yoginder Pal Singh, Narinder K. Mehra. Should We Revisit HLA Matching to Improve Long-Term Graft Outcomes?Current Transplantation Reports 2018; 5(3): 235 doi: 10.1007/s40472-018-0201-1
5
Kaoutar El Morabit, Ouafa Atouf, Sanae Ouadghiri, Kaoutar Aitifiss, Imane Yakhlef, Malika Essakalli. Anticorps anti-Cw, anti-DP et décision de transplantation rénale : à propos de deux casRevue Francophone des Laboratoires 2023; 2023(553): 76 doi: 10.1016/S1773-035X(23)00138-7